Home Page
Chairman's Letter
Committees
Opening Lectures
International Society of Heart
Failure Awards

Thanks

General Information
Social Program
List of Exhibitors
Scientific Program
Satellite Symposium
Monday, July 10, 2000
Registration Form
Accommodation
Form (Word Document)
Back to CARDIOLOGY ONLINE
  SCIENTIFIC PROGRAM

MONDAY,
JULY 10, 2000

TUESDAY, 
JULY 11, 2000

WEDNESDAY,
JULY 12, 2000

 

MONDAY, JULY 10, 2000
09:00-09:30    HALL A
OC:  OPENING CEREMONY
Chairperson: U. Elkayam, Los Angeles CA, USA
 
09:00  GREETINGS

Asher Kimchi, USA
Founder and Chairman
International Society of Heart Failure
7th World Congress of Heart Failure

Pawan K. Singal, Canada
Member Scientific Executive Committee
Chairman, Section of Basic Research
International Society of Heart Failure
7th World Congress on heart Disease

Mihai Gheorghiade, USA
Member, Scientific Executive Committee
Chairman, Section of Coronary Artery Disease
International Society of Heart Failure
7th World Congress on heart Disease

John A. Elefteriades, USA
Member, Scientific Executive Committee
Chairman, Section of Cardiac Surgery
International Society of Heart Failure
7th World Congress on Heart Failure

 
  PRESENTATION OF 2000 AWARDS
Uri Elkayam, USA
Chairman, Scientific Executive Committee
Chairman, Awards Committee
Chairman, Section of Clinical Trials
International Society of Heart Failure
7th World Congress on Heart Failure
 
MONDAY, JULY 10, 2000
09:30-10:15   HALL A
OL:  OPENING LECTURE
Chairperson: A.J. Tajik, Rochester MN, USA 
 
    Abstract Page
 09:30  INTRODUCTION
A.J. Tajik, Rochester MN, USA
Member, Scientific Executive Committee
International Society of Heart Failure
7th World Congress on Heart Failure
 
 09:35  THOMAS W. SMITH MEMORIAL LECTUTE:
THE CELLULAR AND MOLECULAR BASIS OF HEART FAILURE IN VALVULAR REGURGITATION: RELATION TO CLINICAL OUTCOME (Opening Lecture)
J.F. Borer, New York NY, USA
  1
 10:15  Coffee Break  
MONDAY, JULY 10, 2000
10:45-12:45   HALL A
PL01:  Plenary Session:
MOLECULAR BIOLOGY AND GENETIC STUDIES
Chairpersons: J.S. Borer, New York NY, USA R.A. Trent, Campentown NSW, Australia
 
    Abstract Page
 10:45  THE GENETICS OF CARDIOMYOPATHY (Invited Lecture)
R.J.A. Trent, Sydney NSW, Australia
  1
 11:00  ALTERED PHENOTYPE PATTERN UNDERLYING CONTRACTILE DYSFUNCTION IN FAILING HUMAN MYOCARDIUM (Invited Lecture)
B. Pieske, Goettingen, Germany
  1
11:15  SUBCELLULAR REMODELING DURING THE DEVELOPMENT OF CONGESTIVE HEART FAILURE (Invited Lecture)
N.S. Dhalla, Winnipeg MB, Canada 
1
11:30  MOLECULAR MECHANISM OF APOPTOSIS IN HEART (Invited Lecture)
S. Mustapha, O. Zlouzina, D. de Moissac, L.A. Kirshenbaum, Winnipeg MB, Canada 
2
 11:45  APOPTOSIS AND HEART FAILURE - MECHANISMS AND NEW THERAPEUTIC STRATEGIES (Invited Lecture)
G.Z. Feuerstein, Wilmington DE, USA
  2
 12:00  G PROTEIN-COUPLED RECEPTOR KINASES IN THE HEART: ANIMAL MODELS AND THERAPEUTIC IMPLICATIONS (Invited Lecture)
W.J. Koch, Durham NC, USA 
 2
 12:15  MODULATION OF ISCHEMIC MYOCARDIAL DYSFUNCTION BY BETA-ONE ADRENOCEPTOR ANTISENSE (Invited Lecture)
J.L. Mehta, H.J. Chen, D.Y. Li, Gainesville FL, USA 
 2
 12:30  Lunch Break  
MONDAY, JULY 10, 2000
10:45-13:00   HALL B
PL02:  Plenary Session:
NEW DEVELOPMENTS IN CARDIAC IMAGING
Chairpersons: A.P. Furnary, Portland OR, USA 
R.M. Lang, Chicago IL, USA
 
    Abstract Page
 10:45  SUBSTERNAL EPICARDIAL ECHO: A NEW WINDOW TO THE POSTOPERATIVE HEART (Invited Lecture)
A.P. Furnary, R.I. Lowe, J.T. Hanlon, D.J. Sahn, Portland OR, USA 
 3
 11:00  FEASIBILITY OF USING MODIFIED ACOUSTIC QUANTIFICATION WITH ECHOCARDIOGRAPHIC CONTRAST FOR AUTOMATED ENDOCARDIAL BORDER DETECTION AND EVALUATION OF LV FUNCTION (Invited Lecture)
R.M. Lang, J.E. Bednarz, K.T. Spencer, V. Mor-Avi, Chicago, IL, USA 
 3
 11:15  DOPPLER ECHOCARDIOGRAPHY: THE NON-INVASIVE PULMONARY ARTERY CATHETER (Invited Lecture)
M.T. Saltzberg, Chicago IL, USA
  3
 11:30  DECREASED HIGH ENERGY PHOSPHATE RATIOS IN THE MYOCARDIUM OF MEN WITH DIABETES MELLITUS TYPE I
B. Metzler, M.F.H. Schocke, P. Steinboeck, C. Wolf, M. Lechleitner, P. Lukas, O. Pachinger, Innsbruck, Austria
  3
 11:45  CARDIAC FATTY ACID METABOLISM IMAGING WITH CONVENTIONAL NUCLEAR MEDICINE TECHNIQUES FOR PREDICTING OUTCOME IN PATIENTS WITH CHRONIC ISCHEMIC HEART FAILURE
A.S. Hambye, A. Dobboleir, A. Vervaet, M. Vaerenberg, J. Vandevivere, P. Vermeersch, D. Stockman, F. Van den Branden, P. Van den Heuvel, Antwerp, Belgium
  4
 12:00  CORONARY FLOW VELOCITY DISTURBANCES IN PATIENTS WITH SYNDROME X DEMONSTRATED BY DOPPLER FLOW MEASUREMENT
J. Qian, J. Ge, H. Chen, Shanghai, China 
 4
 12:15  NONINVASIVE ASSESSMENT OF CORONARY FLOW RESERVE BY TRANSTHORACIC DOPPLER ECHOCARDIOGRAPHY WITH A HIGH-FREQUENCY TRANSDUCER IN PATIENTS WITH VARIOUS HEART DISEASES
T. Hozumi, T. Akasaka, K. Yoshida, J. Yoshikawa, S. Homma, Kobe, Osaka, Japan, New York NY, USA 
 4
 12:30  PREDICTIVE VALUE OF LOW-DOSE DOBUTAMINE STRESS ECHOCARDIOGRAPHY FOR LEFT VENTRICULAR FUNCTION DYSFUNCTION AFTER HIGH-DOSE CARDIOTOXIC CHEMOTHERAPY
A. Martinoni, M. Civelli, D. Cardinale, G. Lamantia, E. Borghini, C.M. Cipolla, C. Fiorentini, Milan, Italy
  4
 12:45  COMBINED APPLICATION OF PULSED, TISSUE DOPPLER AND 2-D ECHOCARDIOGRAPHY FOR THE DETECTION OF TRANSPLANT REJECTION
J.P. Sun, G. Cheng, J. Xu, J. X. Qin, W.J. Stewart, D. Pelegrin, J.B. Young, M.J. Garcia, J.D. Thomas, Cleveland OH, USA 
 5
13:00  THE ROLE OF ECHOCARDIOGRAPHY IN HEART FAILURE (INVITED LECTURE)
Fausto J. Pinto, Lisbon, Portugal
 
 13:15  Lunch Break  
MONDAY, JULY 10, 2000
10:45-12:30   HALL C
 S51:  Session:
HEART FAILURE IN INFANCY AND CHILDHOOD, CONGENITAL HEART DISEASE
Chairpersons: M.L. Epstein, Detroit MI, USA R.D. Ross, Detroit MI, USA
 
    Abstract Page
 10:45  CATHETER CLOSURE OF ATRIAL SEPTAL DEFECTS WITH THE AMPLATZER OCCLUDER IN 80 ADULTS - AN OUTPATIENT PROCEDURE
H. Sievert, K. Horvath, E.E. Zadan, U. Krumsdorf, R. Schraeder, A. Fach, D. Scherer, R. Ensslen, H. Merle, H. Spies, H. Zeplin, Frankfurt, Germany 
 5
 11:00  LONG TERM EFFECTS OF VENTRICULAR SEPTAL DEFECTS WITH A MODERATE LEFT TO RIGHT SHUNT WITH AND WITHOUT OPERATION
M.D. Talsma, J.P.C. Jaspers, M.T.E. Bink-Boelkens, Groningen, The Netherlands
  5
 11:15  PRE-OPERATIVE ACIDOSIS IN THE NEWBORN PATIENTS PREVENTED BY PRENATAL DIAGNOSIS OF CONGENITAL HEART DISEASE
P.M. Verheijen, L.A. Lisowski, P. Stoutenbeek, J.F. Hitchcock, G.B.W.E. Bennink, J.I. Brenner, J.A. Copel, C.S. Kleinman, E.J. Meijboom, Utrecht, The Netherlands, Baltimore MD, USA 
 5
 11:30  STENT IN AORTIC COARCTATION (AoC): IMMEDIATE RESULTS AND MID-TERM FOLLOW-UP
M. Ledesma, F. David, S. Jimenez, A. Sanchez, A. Diaz, C. Benitez, R. Herrera, X. Escudero, R. Arguero, Mexico D.F., Mexico 
 6
 11:45  INCIDENCE AND TYPES OF VALVE DYSPLASIA IN 170 PULMONARY VALVULOPLASTY PROCEDURES
J. Simon-Lamuela, J. Sanmarti, J. Casaldaliga, C. Sanchez, M. Murtra, Barcelona, Spain 
 6
 12:00  RIGHT VENTRICULAR DYSFUNCTION IN PATIENTS WITH TRANSPOSITION OF THE GREAT ARTERIES: PRELIMINARY RESULTS WITH ACE INHIBITORS
R. Chugh, K. Junge, P. Romero, P. Barger, D. Kelly, P. Ludbrook, St. Louis MO, USA
  6
 12:15  MULTIPLE CARDIAC VALVE REGURGITATION IN MARFAN SYNDROME
M.C. Porciani, L. Giurlani, B. Giusti, P. Martinucci, T. Brunelli, L. Evangelisti, R. Abbate, G.F. Gensini, G. Pepe, Florence, Rome, Italy
 6 
 12:30  Lunch Break  
MONDAY, JULY 10, 2000
10:45-12:45   HALL D
  S52: Session:
ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR ANTAGONISTS
Chairpersons: S. Goldstein, Detroit MI, USA B.N. Singh, Los Angeles CA, USA
 
    Abstract Page
 10:45  SERUM ERYTHROPOIETIN LEVELS IN HEART FAILURE PATIENTS ARE TENDENTIALLY HIGHER IF THEY ARE TREATED WITH AT1 RECEPTOR ANTAGONISTS COMPARED WITH AN ACE-INHIBITOR
B. Chatterjee, U.E. Nydegger, P.J. Mohacsi, Bern, Switzerland 
 7
 11:00  CHOICE OF ACE INHIBITOR INFLUENCES ACHIEVEMENT OF TARGET DOSES IN HEART FAILURE PATIENTS
A.B. Luzier, L. DiTusa, D.M. Triller, J.L. Izzo, Jr., Buffalo NY, USA 
 7
11:15  CARDIOPROTECTION INDUCED BY ANGIOTENSIN II TYPE 1 RECEPTOR ANTAGONIST, CANDESARTAN, IS ASSOCIATED WITH INCREASED ANGIOTENSIN III TYPE 2 RECEPTOR PROTEIN BUT NOT APOPTOSIS
R. Moudgil, Y. Xu, S. Musat-Marcu, B.I. Jugdutt, Edmonton AB, Canada 
7
11:30  DISPARITY OF THERAPEUTIC HEART FAILURE GUIDELINES AND STANDARD CLINICAL PRACTICE
F. Smart, S. Battaglia, L. Tarkington, S. Culler, E. Becker, A. Simon, H.O. Ventura, New Orleans LA, USA 
7
11:45  THE CARDIOVASCULAR MORTALITY AND MORBIDITY OF CANDESARTAN IN CHF
E. Erdmann, M. George, B. Voet, G. Belcher, D. Kolb, M. Pietrek, Cologne, Mannheim, Germany, London, UK 
8
12:00  ACEI THERAPY IN CHF PATIENTS TOO ILL TO QUALIFY FOR EVIDENCE BASED CLINICAL TRIALS
K.O. Akosah, A.M. Schaper, K. Briggs, R. Sundaram, S. Devine, La Crosse WI, USA 
8
12:15  EFFECTS OF LOSARTAN VERSUS LISINOPRIL ON SYSTOLIC, DIASTOLIC AND CARDIOPULMONARY FUNCTION IN HEART FAILURE
A.C. Hunt, P. Manning, C. Denslow, M. Burrows, M.A. James, Somerset, UK 
8
 12:30  EFFECTS OF LOSARTAN ON THE QUALITY OF LIFE AND MORTALITY IN SEVERE ISCHEMIC HEART FAILURE WITH CHRONIC PULMONARY HEART DISEASE
X. Zeng, Y. Lee, X. Zeng, Chengdu, China 
 8
 12:45  Lunch Break  
MONDAY, JULY 10, 2000
08:30-13:00    POSTER AREA
 P101:  Poster Session:
VASCULAR BIOLOGY, ENDOTHELIAL FUNCTION
 
Board No.    Abstract Page
 1  TRANSFECTION OF AN ADENOVIRUS-MEDIATED RAS MUTANT ALL EVIATES THE RESTENOTIC LESIONS OF CORONARY ARTERY INJURY IN PIGS
C.S. Lin, C.H. Wu, C.J. Wu, R.S. Hung, Y.J. Shyy, S. Chien, S.-K. Liu, Miaoli, Taiwan-R.O.C., San Diego CA, USA 
 9
 2  FIBRINOLYTIC BALANCE DISORDERS AND ENDOTHELIAL DYSFUNCTION IN ESSENTIAL HYPERTENSION: THE EFFECT OF ACE GENOTYPE
O. Stavroulakis, A. Hatzizacharias, T. Makris, P. Krespi, G. Anastasiadis, E. Chronakis, N. Hatzizacharias, M. Kyriakidis, Athens, Greece 
 9
 3  POTENTIAL ATHEROGENIC EFFECTS OF SHORT-TERM HIGH DOSE GROWTH HORMONE TREATMENT IN THE RAT MODEL
S. Coskun, B. Ersoy, C. Sekuri, K. Ozbilgin, M. Yurtseven, A. Onag, Izmir, Turkey 
 9
 4  LIPOPROTEINS ARE TRIGGERS OF OXIDATIVE STRESS IN PATIENTS WITH DYSLIPIDEMIA
J. Eckes, B. Fink, O. Sommer, H. Weise, K. Winkler, W. Maerz, E. Bassenge, Freiburg, Germany 
 9
 5  INCREASED OXIDATIVE STRESS IN PATIENTS WITH HYPERCHOLESTEROLEMIA AND CORONARY ARTERY DISEASE IS NORMALIZED AFTER HELP APHERESIS
J. Eckes, B. Fink, O. Sommer, W. Maerz, E. Bassenge, Freiburg, Germany
  10
 6  ISCHEMIC MITRAL REGURGITATION REPAIR - PREVENTION OF CONGESTIVE HEART FAILURE
K. Golba, J. Biernat, K. Widenka, R. Mrozek, M. Deja, R. Bachowski, S. Wos, Katowice, Poland 
 10
 7  ESTIMATION OF VESSEL WALL CONDITION IN VIVO ACCORDING TO THE SPECTRUM OF TONES BY KOROTKOV
N.N. Alexandrova, V.N. Bakutsky, P.I. Romanchuk, A.N. Volobuyev, Samara, Russia
  10
 8  DIVERGENT VASOMOTOR EFFECT OF CONTRAST MEDIA ON HEALTHY AND DISEASED CORONARY
G. Musumeci, U. Limbruno, A.S. Petronio, R. Baglini, G. Paterni, R. De Caterina, R. Mariotti, M. Mariani, Pisa, Italy 
 10
THE EFFECT OF LEFT VENTRICULAR HYPERTROPHY ON FLOW-MEDIATED DILATATION OF THE BRACHIAL ARTERY
M. Zoghi, E. Ercan, C. Gurgun, C. Ceyhan, O. Yavuzgil, F. Ozerkan, A. Akilli, C. Turkoglu, M. Akin, Izmir, Turkey 
11
MONDAY, JULY 10, 2000
08:30-13:00    POSTER AREA
P102:  Poster Session:
NEUROHORMONAL, IMMUNOLOGIC ASPECTS OF HEART FAILURE
 
Board No.   Abstract Page
 10  SEQUENTIAL NEURO-HUMORAL CHANGES IN OVINE MODEL OF SURGICALLY INDUCED HEART FAILURE
A.K. Hasnat Buckley, H.J. Kemp, M.H. Yacoub, London, UK 
 11
 11  NEUROHORMONAL CHANGES IN PATIENTS WITH ISCHEMIC HEART FAILURE AFTER 6 MONTHS OF CARDIAC REHABILITATION
B. Bacior, A. Kubinyi, W. Szot, I. Guevara, A. Zdzienicka, A. Dembinska-Kiec, K. Kawecka-Jaszcz, Krakow, Poland 
 11
 12  DOES ALDOSTERONE "ESCAPE" IN CHRONIC HEART FAILURE RELATE TO FUNCTIONAL IMPAIRMENT?
M. Cicoira, L. Zanolla, L. Franceschini, G. Brighetti, G. Golia, A. Rossi, P. Zardini, Verona, Italy 
 11
 13  MODIFIED CIRCADIAN RHYTHM OF THE IMMUNOMODULATING DEHYDROEPIANDROSTERONE-SULFATE (DHEAS) IN CORONARY ARTERY DISEASE (CAD) AND REDUCED LEFT VENTRICULAR (LV) FUNCTION
K. Gunther, M. Mueller, S. Kraemer, E. Schulze-Bahr, P. Loh, B. Brisse, Muenster, Germany 
 12
 14  INFLUENCE OF ANAPHYLACTIC SHOCK AND AGE ON THE RESERVE OF MYOCARDIAL ISOMETRIC CONTRACTILITY
Z. Senikiene, E. Stankevicius, Kaunas, Lithuania 
 12
 15  ACTIONS OF PROSTAGLANDINS (E1, F2 a) AND CYCLIC NUCLEOTIDES (cAMP, cGMP) DISTURBANCES ON THE CARDIOVASCULAR FUNCTIONS DURING PRIMARY AND REPEATED ANAPHYLACTIC SHOCK
P. Cibas, B. Ruta, J. Ivaskeviciene, R. Obeleniene, S. Rutiene, Kaunas, Lithuania 
 12
 16  ROLE OF HISTAMINE H1 AND H2 RECEPTORS IN ANAPHYLACTIC REACTION OF THE CONTRACTILE MYOCARDIUM
R. Lazauskas, Z. Senikiene, Kaunas, Lithuania
  12
17  IMPORTANCE OF NEUROHUMORAL ACTIVATION FOR THE EXPRESSION OF NA+-CA2+ EXCHANGER IN END-STAGE FAILING HUMAN MYOCARDIUM
W. Schillinger, R. Ferrari, G. Hasenfuss, Goettingen, Germany 
13
 18  THE KINETICS OF NEUROHUMORAL FACTORS IN ACUTE MYOCARDIAL INFARCTION
H. Lapp, J.P. Stasch, I. Krakau, H. Guelker, M. Mueller, Wuppertal, Germany 
 13
MONDAY, JULY 10, 2000
08:30-13:00    POSTER AREA
P103:  Poster Session:
HEART FAILURE DUE TO CORONARY ARTERY DISEASE
 
Board No.    Abstract Page
 19  CHF HISTORY IS ASSOCIATED WITH MORE ADVANCED CORONARY DISEASE
A. Simon, F. Smart, S. Battaglia, L. Turkington, S. Culler, E. Becker, H.O. Ventura, New Orleans LA, USA 
 13
 20  PLATELET ACTIVITY IN PATIENTS WITH ACUTE CORONARY SYNDROMES AND CONGESTIVE HEART FAILURE IN BACKGROUND
V.Z. Netiazhenko, O.R. Dotsenko, O.M. Plenova, T. Malchevska, O.V. Lapshin, Kyev, Ukraine
  13
 21  2 YEAR FOLLOW-UP OF PATIEN ATS WITH LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION
M.G. Glezer, I.V. Persianov-Dubrov, I.N. Sokolova, A.V. Prikhodchenko, K.E. Sobolev, Moscow, Russia 
 14
 22  A NEW INSIGHT INTO PATHOGENESIS OF HEART FAILURE IN PATIENTS WITH CORONARY ARTERY DISEASE (CAD)
N. Mamaev, A. Gudkova, K. Amineva, O. Kovalyeva, T. Gindina, I. Bannikova, St. Petersburg, Russia 
 14
 23  ANTIPHOSPHOLIPID ANTIBODIES AND OTHER THROMBOGENIC FACTORS IN YOUNG PATIENTS WITH MYOCARDIAL INFARCTION
C. Carp, C. Ginghina, V. Uscatescu, D. Colita, D. Chesta, C. Ceck, E. Apetrei, Bucharest, Romania
  14
 24  RISK OF HEART FAILURE IN PATIENTS WITH MILD INFARCT-RELATED MITRAL REGURGITATION AFTER Q-WAVE MYOCARDIAL INFARCTION - LONG TERM FOLLOW UP
M. Zielinska, W. Koniarek, E. Kot, H. Bolinska, Lodz, Poland
  14
25  CAN HEART RATE IDENTIFY PATIENTS AT RISK FOR VENTRICULAR REMODELING AFTER SMALL TO MODERATE MYOCARDIAL INFARCTION?
G.M. Costa, C. Pizzi, G. Bedetti, R. Bugiardini, Bologna, Italy 
15
 26  MYOCARDIAL VIABILITY INDEPENDENTLY INFLUENCES LV DIASTOLIC FUNCTION AFTER ACUTE MYOCARDIAL INFARCTION
M. Cicoira, A. Rossi, G. Golia, M. Anselmi, L. Latina, P. Marino, P. Zardini, Verona, Italy
  15
MONDAY, JULY 10, 2000
08:30-13:00    POSTER AREA
P104:  Poster Session:
ISCHEMIC CARDIOMYOPATHY
 
Board No.    Abstract Page
 27  FREE PATCH CARDIOMYOPLASTY
S.A. Taheri, H.J. Leonhardt, R. Heffner, M. Wilson, A. Grover, Buffalo NY, USA 
 15
 28  LEFT VENTRICULAR FUNCTION AND SERUM CYTOKINES LEVEL IN PATIENTS WITH CORONARY HEART DISEASE
T. Mandecki, K. Mizia-Stec, B. Zahorska-Markiewicz, J. Janowska, A. Szulc, E. Jastrzebska-Maj, L. Szymanski, Katowice, Poland 
 15
 29  PREDICTORS OF THE APPEARANS OF REAL HEART FAILURE IN CHRONIC HAEMODIALYSIS PATIENTS
M.E. Krotin, B. Milovanovic, O. Stojanovic, A. Cavalo, S. Pljesa, D. Lisulov, Belgrade, Yugoslavia 
 16
MONDAY, JULY 10, 2000
08:30-13:00   POSTER AREA
P105:  Poster Session:
LEFT VENTRICULAR HYPERTROPHY
 
Board No.    
 30  RELATION BETWEEN SEQUENTIAL MEASUREMENTS OF LEFT VENTRICULAR DIASTOLIC FILLING AND INSTANTANEOUS MEASUREMENT OF BLOOD PRESSURE BY ABPM IN PATIENTS WITH ESSENTIAL HYPERTENSION
A. Cwetsch, A. Skrobowski, M. Cholewa, G. Kaminski, K. Makowski, L. Kubik, Warsaw, Poland 
 16
 31  ECHOCARDIOGRAPHIC REFERENCE RANGES AND ECG FINDINGS IN YOUTH PROFESSIONAL SOCCER PLAYERS
J.D. Somauroo, J.R. Pyatt, M. Jackson, R.A. Perry, D.R. Ramsdale, Liverpool, UK 
 16
 32  THE INFLUENCE OF THE CORONARY CIRCULATION ON LEFT VENTRICULAR DIASTOLIC FUNCTION
M. Zhong, Y. Zhang, W. Zhang, Z. Ge, Jinan, China 
 16
 33  RELATIONSHIP BETWEEN CARDIAC VOLUME, MUSCLE MASS AND LEFT VENTRICULAR PRESSURE: A LEFT VENTRICULAR PRESSURE-VOLUME RELATIONSHIP WITH A POSSIBLE APPLICATION TO THE PHYSIOLOGY OF VENTRICULAR RESECTION IN CONGESTIVE HEART FAILURE
W. Seitz, San Francisco CA, USA 
 17
 34  BLOOD PRESSURE PROFILE IN ELDERLY PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION: RELATIONSHIP WITH LEFT VENTRICULAR HYPERTROPHY AND SILENT CEREBROVASCULAR DAMAGE
C. Moroni, M. Nanetti, C. Affricano, R. Cassone, Rome, Italy 
 17
MONDAY, JULY 10, 2000
08:30-13:00    POSTER AREA
P105:  Poster Session:
LEFT VENTRICULAR HYPERTROPHY (cont'd)
 
Board No.    Abstract Page
 35  LEFT VENTRICULAR HYPERTROPHY: THE DILEMMA BETWEEN STRAIN AND ISCHEMIA
A.C.F. De Lara Llarena, J.D. Verzosa, F.G. Dizon, R.E. Ramboyong, Manila, Philippines
  17
36  EFFICACY OF LERCANEDIPINE VS LOSARTAN ON LEFT VENTRICULAR HYPERTROPHY IN HYPERTENSIVE TYPE 2 DIABETIC PATIENTS
R. Fogari, A. Mugellini, L. Corradi, P. Preti, A. Zoppi, P. Lazzari, M. Pasotti, Pavia, Italy 
17
 37  THE TRANSESOPHAGEAL ECHOCARDIOGRAPHIC STUDIES OF RELATIONSHIP BETWEEN DIASTOLIC LEFT VENTRICULAR FUNCTION AND CORONARY BLOOD FLOW
W. Zhang, L.-L. Wei, Y. Zhang, M. Zhong, X.-P. Ji, Jinan, China 
 18
 38  INFLUENCE OF THE NIFEDIPINE ON LEFT VENTRICULAR HYPERTROPHY IN ESSENTIAL HYPERTENSIVE PATIENTS
A. Qawir Khan, Z. Ali, F. Alam, M. Alam Khan, Mingora, Pakistan 
 18
 39  REACTION OF HYPERTROPHIED MYOCARDIUM IN ESSENTIAL HYPERTENSIVE (EHTN) PATIENTS ON STRESS TEST
A. Qawir Khan, Z. Ali, F. Alam, Mingora, Pakistan 
 18
MONDAY, JULY 10, 2000
08:30-13:00    POSTER AREA
P106:  Poster Session:
PULMONARY CIRCULATION ASPECTS, PULMONARY HYPERTENSION
 
Board No.    Abstract Page
 40  IS NON INVASIVE DIFFERENTIATION OF PRIMARY PULMONARY HYPERTENSION AND PULMONARY THROMBOEMBOLISM FEASIBLE USING TRANSTHORACIC ECHOCARDIOGRAPHY?
L. Scelsi, S. Ghio, A. Gavazzi, F. Recusani, C. Raineri, A. Repetto, A. Darmini, M. Vigano, L. Tavazzi, Pavia, Italy
 19
 41  THROMBOLYTIC THERAPY IN THE TREATMENT OF THROMBOEMBOLISM OF THE RIGHT ATRIAL CAVITY DURING PULMONARY EMBOLISM: OUR EXPERIENCE WITH rt-PA AND ONE-YEAR FOLLOW-UP WITH ECHOCARDIOGRAPHY DOPPLER
G. Pierre-Justin, M. Garrique, P. Jeanneaux, R. Beauzile, Fort de France (Martinique), France 
 19
MONDAY, JULY 10, 2000
08:30-13:00 
 
POSTER AREA
P106:  Poster Session:
PULMONARY CIRCULATION ASPECTS, PULMONARY HYPERTENSION (cont'd)
 
Board No.    Abstract Page
 42  PULMONARY BLOOD FLOW DISTRIBUTION AFTER THE TOTAL CAVOPULMONARY CONNECTION
M. Tayama, N. Hirata, T. Matsushita, N. Fukushima, Y. Sawa, H. Matsuda, Osaka, Japan 
 19
 43  CONTINUOUS EPOPROSTENOL INFUSION IN PRIMARY AND SECONDARY PULMONARY HYPERTENSION; A PRELIMINARY EXPERIENCE
C. Campana, A. Gavazzi, L. Scelsi, S. Ghio, A. Repetto, M. Ceresa, A. Fontana, L. Tavazzi, Pavia, Italy 
 19
 44  INCIDENCE OF CHEYNE-STOKES RESPIRATION IN PATIENTS WITH DIFFERENT KINDS OF HEART FAILURE
M. Rossi, M. Contini, P. Moruzzi, Milan, Italy 
 20
 45  SUCCESSFUL TREATMENT OF RIGHT HEART THROMBOEMBOLI (RHT) WITH IV rtPA: FOLLOW-UP AT 12 MONTHS
G. Pierre-Justin, M. Garrigue, P. Jeanneaux, R. Beauzile, Fort de France (Martinique), France 
 20
 46  S-NITROSOGLUTATHIONE IS A PROMISING NITRIC OXIDE DONOR FOR THE TREATMENT OF EXPERIMENTAL RAT PULMONARY HYPERTENSION
J. Kobayashi, M. Sonoda, T. Miyazaki, E. Hirakawa, M. Takezawa, T. Seiya, S. Masutani, M. Nogaki, H. Senzaki, T. Kobayashi, T. Komoda, Tokyo, Japan 
 20
MONDAY, JULY 10, 2000
08:30-13:00   POSTER AREA
 P107:  Poster Session:
HEART FAILURE IN SYSTEMIC DISEASE
 
Board No.   Abstract Page
 47  DIFFERENCES IN RIGHT VENTRICULAR DIASTOLIC FUNCTION BETWEEN PATIENTS WITH b-THALASSEMIA MAJOR WITH NORMAL AND ABNORMAL LEFT VENTRICULAR SYSTOLIC FUNCTION
I. Moyssakis, E. Voskaridou, P. Voyatzi, D. Drosos, G. Anastasiadis, M. Kyriakidis, D. Loukopoulos, Athens, Greece 
 20
48  BLOOD PRESSURE PROFILE IN ACROMEGALICS: EFFECTS OF TRANSSPHENOIDAL SURGERY
C. Moroni, G. Minniti, M.L. Jaffrain Rea, M. Nanetti, C. Affricano, G. Tamburrano, R. Cassone, Rome, L'Aquila, Italy 
21
 49  MYOCARDIAL INJURY IN ENTERIC FEVERS
M. Sharma, M. Bhutani, V.K. Sharma, H.K. Aggarwal, N. Nand, Rohtak, India 
 21
MONDAY, JULY 10, 2000
08:30-13:00    POSTER AREA
P107:  Poster Session:
HEART FAILURE IN SYSTEMIC DISEASE (cont'd)
 
Board No.   Abstract Page
 50  EVOLUTION OF CARDIAC LESIONS IN SYSTEMIC SCLEROSIS
I. Moyssakis, V. Vasiliou, F. Triposkiadis, G. Anastasiadis, D. Drosos, M. Kyriakidis, Athens, Greece
  21
 51  ECHOCARDIOGRAPHIC EVALUATION OF 117 CHILDHOOD CANCER LONG TERM SURVIVORS
G. Bossi, L. Lanzarini, M.L. Laudisa, C. Klersy, A. Ricci, A. Raisaro, M. Arico, Pavia, Italy 
 21
 52  CARDIAC MANIFESTATIONS IN ANKYLOSING SPONDYLITIS
I. Moyssakis, E. Batzoglou, V. Vasiliou, F. Triposkiadis, M. Kyriakidis, Athens, Greece
 22 
 53  LOW-DOSE DOBUTAMINE ECHO STRESS FOR EVALUATION OF ASYMPTOMATIC LONG-TERM SURVIVORS OF CHILDHOOD CANCER
G. Bossi, A. Raisaro, C. Klersy, M. Arico, M.L. Laudisa, V.S. Russotto, Pavia, Italy
 22 
MONDAY, JULY 10, 2000
08:30-13:00   POSTER AREA
P108:  Poster Session:
PREDICTORS AND MARKERS OF HEART FAILURE OUTCOME
 
Board No.    Abstract Page
 54  CHANGES OF CARDIAC TROPONIN T FOLLOWING COMBINATION OF DAUNORUBICIN WITH NEW ANTINEOPLASTIC DRUGS
M. Adamcova, V. Gersl, J. Machackova, R. Hrdina, M. Melka, M. Nobilis, V. Mazurova, Hradec Kralove, Czech Republic
  22
 55  FREQUENCY AND PREDICTORS OF IMPROVEMENT OF LV FUNCTION IN PATIENTS WITH "PURE" IDIOPATHIC DCM
M. Cicoira, L. Zanolla, L. Latina, A. Rossi, G. Golia, G. Brighetti, P. Zardini, Verona, Italy 
 22
 56  COMPARISON OF HOSPITAL LENGTH OF STAY AND READMISSION RATE BETWEEN PATIENTS WITH PRESERVED AND DECREASED LEFT VENTRICULAR FUNCTION
Q. Malki, N.D. Sharma, A. Afzal, K. Ananthsubramaniam, A. Abbas, G. Jacobson, S. Jafri, Detroit MI, USA 
 23
 57  FAS SERUM LEVELS ARE NOT INCREASED IN CACHECTIC HEART FAILURE PATIENTS
G. Filippatos, K. Tsilias, K. Venetsanou, J. Koutras, D. Manolatos, E. Karambinos, D. Economou, A. Kranidis, N. Sfougaris, F. Kardaras, L. Anthopoulos, G. Baltopoulos, Athens, Greece
 23 
 58  PEAK CARDIAC POWER OUTPUT PREDICTS PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE
S.G. Williams, G.A. Cooke, D.J. Wright, W. Parsons, L.B. Tan, Leeds, UK
 23 
MONDAY, JULY 10, 2000
14:00-15:45